BIOLQ.US Biolase Inc

Healthcare Medical Devices USA Stocks
0.0001 USD
Close of Nov 14, 2026
0.0001 0.0002
Market cap
USD 3.66K
P/E
-
P/B
0.77x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2024.

Is BIOLQ.US undervalued?

Graham number

The Graham number of Biolase Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Biolase Inc fundamental analysis

No fundamental analysis for Biolase Inc yet.

Biolase Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Biolase Inc

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterl…

Full company profile